Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

BPH treatments can cause sexual side effects affecting quality of life.

Tamsulosin hydrochloride is safe and effective for long-term treatment of urinary symptoms in BPH patients.

Statins do not impact BPH and LUTS progression when combined with finasteride.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Obesity is linked to more severe lower urinary tract symptoms.

Men with better urinary symptoms have a lower risk of death.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

UTIs are common in Upper Egypt, with many bacteria resistant to multiple drugs, highlighting the need for better treatment strategies.

Older adults on certain medications should be carefully monitored for urinary issues and low sodium levels.